Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1989-05

AUTHORS

Hiroshi Ujike, Taichi Onoue, Kazufumi Akiyama, Takashi Hamamura, Saburo Otsuki

ABSTRACT

The present study examined effects of selective antagonists of D-1 and D-2 dopamine receptors on the development of behavioral sensitization produced by repeated methamphetamine (MAP) administration. Male Sprague-Dawley rats were divided into four groups. Each group received a daily injection of saline (control group), 4 mg/kg MAP (MAP group), 1 mg/kg YM-09151-2 plus 4 mg/kg MAP (YM+MAP group) or 0.5 mg/kg SCH 23390 plus 4 mg/kg MAP (SCH+MAP group) for 14 days. During daily injection for 14 days, the MAP group exhibited a progressive augmentation in locomotor and stereotyped behavior, whereas the progression of such behaviors in the YM+MAP and SCH+MAP group was completely prevented. After an abstinence period of 7 days, all groups received a challenge of 2 mg/kg MAP. The MAP challenge reproduced hyperlocomotion and intense stereotyped behavior only in the MAP group. However, neither the YM+MAP group nor the SCH+MAP group showed sterotypy. The manner in which both groups showed only hyperlocomotion was similar to that observed in the control group. These results indicate that both selective D-1 antagonists and selective D-2 antagonists not only reverse MAP-induced motor effects at each injection but also prevent the development of behavioral sensitization induced by repeated MAP administration. More... »

PAGES

89-92

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00442011

DOI

http://dx.doi.org/10.1007/bf00442011

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1047686003

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2498964


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Behavior, Animal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dopamine Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methamphetamine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Inbred Strains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stereotyped Behavior", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.261356.5", 
          "name": [
            "Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ujike", 
        "givenName": "Hiroshi", 
        "id": "sg:person.01222444440.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222444440.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.261356.5", 
          "name": [
            "Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Onoue", 
        "givenName": "Taichi", 
        "id": "sg:person.0702337163.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702337163.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.261356.5", 
          "name": [
            "Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Akiyama", 
        "givenName": "Kazufumi", 
        "id": "sg:person.0713327777.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713327777.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.261356.5", 
          "name": [
            "Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hamamura", 
        "givenName": "Takashi", 
        "id": "sg:person.01165304675.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165304675.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.261356.5", 
          "name": [
            "Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Otsuki", 
        "givenName": "Saburo", 
        "id": "sg:person.01134315436.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134315436.13"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00496365", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020363995", 
          "https://doi.org/10.1007/bf00496365"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00439108", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018127107", 
          "https://doi.org/10.1007/bf00439108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00432713", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051366226", 
          "https://doi.org/10.1007/bf00432713"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1989-05", 
    "datePublishedReg": "1989-05-01", 
    "description": "The present study examined effects of selective antagonists of D-1 and D-2 dopamine receptors on the development of behavioral sensitization produced by repeated methamphetamine (MAP) administration. Male Sprague-Dawley rats were divided into four groups. Each group received a daily injection of saline (control group), 4 mg/kg MAP (MAP group), 1 mg/kg YM-09151-2 plus 4 mg/kg MAP (YM+MAP group) or 0.5 mg/kg SCH 23390 plus 4 mg/kg MAP (SCH+MAP group) for 14 days. During daily injection for 14 days, the MAP group exhibited a progressive augmentation in locomotor and stereotyped behavior, whereas the progression of such behaviors in the YM+MAP and SCH+MAP group was completely prevented. After an abstinence period of 7 days, all groups received a challenge of 2 mg/kg MAP. The MAP challenge reproduced hyperlocomotion and intense stereotyped behavior only in the MAP group. However, neither the YM+MAP group nor the SCH+MAP group showed sterotypy. The manner in which both groups showed only hyperlocomotion was similar to that observed in the control group. These results indicate that both selective D-1 antagonists and selective D-2 antagonists not only reverse MAP-induced motor effects at each injection but also prevent the development of behavioral sensitization induced by repeated MAP administration.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf00442011", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1085440", 
        "issn": [
          "0033-3158", 
          "1432-2072"
        ], 
        "name": "Psychopharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "98"
      }
    ], 
    "keywords": [
      "behavioral sensitization", 
      "daily injections", 
      "methamphetamine-induced behavioral sensitization", 
      "male Sprague-Dawley rats", 
      "stereotyped behavior", 
      "Sprague-Dawley rats", 
      "intense stereotyped behavior", 
      "MAP group", 
      "MAP administration", 
      "SCH 23390", 
      "methamphetamine administration", 
      "motor effects", 
      "YM-09151", 
      "dopamine receptors", 
      "dopamine antagonists", 
      "selective antagonist", 
      "control group", 
      "abstinence period", 
      "antagonist", 
      "progressive augmentation", 
      "sensitization", 
      "hyperlocomotion", 
      "injection", 
      "administration", 
      "present study", 
      "MAP challenge", 
      "days", 
      "group", 
      "rats", 
      "sterotypy", 
      "progression", 
      "saline", 
      "receptors", 
      "locomotor", 
      "effect", 
      "augmentation", 
      "development", 
      "period", 
      "study", 
      "manner", 
      "challenges", 
      "results", 
      "behavior", 
      "such behavior", 
      "maps", 
      "reverse map"
    ], 
    "name": "Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization", 
    "pagination": "89-92", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1047686003"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00442011"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2498964"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00442011", 
      "https://app.dimensions.ai/details/publication/pub.1047686003"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_206.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf00442011"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00442011'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00442011'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00442011'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00442011'


 

This table displays all metadata directly associated to this object as RDF triples.

184 TRIPLES      22 PREDICATES      85 URIs      74 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00442011 schema:about N054531918ce24d6b91ce1538953df396
2 N0c1e6a8b1c5247ec8658c6f9b67a10a6
3 N3ffde95bb1f0472da67e40c3a666cf70
4 N4eabd965b58f41bf953c7bb1762e128c
5 N9035b562a60d48d78970fc3ffd3ecbea
6 Na0781704c6704f3b8fcc31182e4da082
7 Nbf017a247ea249d6aa3c124641fd93d6
8 Nf8d0a446bbbd4d0fbbb3ff601395a275
9 Nfd762ae53f7942e7b7abd3d64e436418
10 anzsrc-for:11
11 anzsrc-for:1109
12 schema:author N3b39b7e7940d42efbf4418a5445d949a
13 schema:citation sg:pub.10.1007/bf00432713
14 sg:pub.10.1007/bf00439108
15 sg:pub.10.1007/bf00496365
16 schema:datePublished 1989-05
17 schema:datePublishedReg 1989-05-01
18 schema:description The present study examined effects of selective antagonists of D-1 and D-2 dopamine receptors on the development of behavioral sensitization produced by repeated methamphetamine (MAP) administration. Male Sprague-Dawley rats were divided into four groups. Each group received a daily injection of saline (control group), 4 mg/kg MAP (MAP group), 1 mg/kg YM-09151-2 plus 4 mg/kg MAP (YM+MAP group) or 0.5 mg/kg SCH 23390 plus 4 mg/kg MAP (SCH+MAP group) for 14 days. During daily injection for 14 days, the MAP group exhibited a progressive augmentation in locomotor and stereotyped behavior, whereas the progression of such behaviors in the YM+MAP and SCH+MAP group was completely prevented. After an abstinence period of 7 days, all groups received a challenge of 2 mg/kg MAP. The MAP challenge reproduced hyperlocomotion and intense stereotyped behavior only in the MAP group. However, neither the YM+MAP group nor the SCH+MAP group showed sterotypy. The manner in which both groups showed only hyperlocomotion was similar to that observed in the control group. These results indicate that both selective D-1 antagonists and selective D-2 antagonists not only reverse MAP-induced motor effects at each injection but also prevent the development of behavioral sensitization induced by repeated MAP administration.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree false
22 schema:isPartOf N5833d816e78946c78e38672bebf78172
23 Na4f36fceb7bd4a8ba2af1dec220a474d
24 sg:journal.1085440
25 schema:keywords MAP administration
26 MAP challenge
27 MAP group
28 SCH 23390
29 Sprague-Dawley rats
30 YM-09151
31 abstinence period
32 administration
33 antagonist
34 augmentation
35 behavior
36 behavioral sensitization
37 challenges
38 control group
39 daily injections
40 days
41 development
42 dopamine antagonists
43 dopamine receptors
44 effect
45 group
46 hyperlocomotion
47 injection
48 intense stereotyped behavior
49 locomotor
50 male Sprague-Dawley rats
51 manner
52 maps
53 methamphetamine administration
54 methamphetamine-induced behavioral sensitization
55 motor effects
56 period
57 present study
58 progression
59 progressive augmentation
60 rats
61 receptors
62 results
63 reverse map
64 saline
65 selective antagonist
66 sensitization
67 stereotyped behavior
68 sterotypy
69 study
70 such behavior
71 schema:name Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization
72 schema:pagination 89-92
73 schema:productId N4b1a497fde244207a72d7525ac533656
74 N8442b39dbf344d4895305592ee0a3794
75 Nb823a7ac8bb743899d7b25583f6d736d
76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047686003
77 https://doi.org/10.1007/bf00442011
78 schema:sdDatePublished 2022-05-20T07:18
79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
80 schema:sdPublisher Nec6f7d9cfac44d91b0a4c477bfa86dce
81 schema:url https://doi.org/10.1007/bf00442011
82 sgo:license sg:explorer/license/
83 sgo:sdDataset articles
84 rdf:type schema:ScholarlyArticle
85 N054531918ce24d6b91ce1538953df396 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Rats
87 rdf:type schema:DefinedTerm
88 N0c1e6a8b1c5247ec8658c6f9b67a10a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Blood Pressure
90 rdf:type schema:DefinedTerm
91 N3b39b7e7940d42efbf4418a5445d949a rdf:first sg:person.01222444440.80
92 rdf:rest N55c32c147bc546e987d36c8f5728a816
93 N3ffde95bb1f0472da67e40c3a666cf70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Rats, Inbred Strains
95 rdf:type schema:DefinedTerm
96 N4b1a497fde244207a72d7525ac533656 schema:name doi
97 schema:value 10.1007/bf00442011
98 rdf:type schema:PropertyValue
99 N4eabd965b58f41bf953c7bb1762e128c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Dopamine Antagonists
101 rdf:type schema:DefinedTerm
102 N55c32c147bc546e987d36c8f5728a816 rdf:first sg:person.0702337163.01
103 rdf:rest Ne776f57fd4c545cf82debb179d71265f
104 N5833d816e78946c78e38672bebf78172 schema:issueNumber 1
105 rdf:type schema:PublicationIssue
106 N5a53894595d34af8b3baaa078ef1aeb7 rdf:first sg:person.01134315436.13
107 rdf:rest rdf:nil
108 N8442b39dbf344d4895305592ee0a3794 schema:name dimensions_id
109 schema:value pub.1047686003
110 rdf:type schema:PropertyValue
111 N9035b562a60d48d78970fc3ffd3ecbea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Animals
113 rdf:type schema:DefinedTerm
114 Na0781704c6704f3b8fcc31182e4da082 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Male
116 rdf:type schema:DefinedTerm
117 Na4f36fceb7bd4a8ba2af1dec220a474d schema:volumeNumber 98
118 rdf:type schema:PublicationVolume
119 Na54e39b19d6349c1973ad8de6558e587 rdf:first sg:person.01165304675.60
120 rdf:rest N5a53894595d34af8b3baaa078ef1aeb7
121 Nb823a7ac8bb743899d7b25583f6d736d schema:name pubmed_id
122 schema:value 2498964
123 rdf:type schema:PropertyValue
124 Nbf017a247ea249d6aa3c124641fd93d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Methamphetamine
126 rdf:type schema:DefinedTerm
127 Ne776f57fd4c545cf82debb179d71265f rdf:first sg:person.0713327777.20
128 rdf:rest Na54e39b19d6349c1973ad8de6558e587
129 Nec6f7d9cfac44d91b0a4c477bfa86dce schema:name Springer Nature - SN SciGraph project
130 rdf:type schema:Organization
131 Nf8d0a446bbbd4d0fbbb3ff601395a275 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Behavior, Animal
133 rdf:type schema:DefinedTerm
134 Nfd762ae53f7942e7b7abd3d64e436418 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Stereotyped Behavior
136 rdf:type schema:DefinedTerm
137 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
138 schema:name Medical and Health Sciences
139 rdf:type schema:DefinedTerm
140 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
141 schema:name Neurosciences
142 rdf:type schema:DefinedTerm
143 sg:journal.1085440 schema:issn 0033-3158
144 1432-2072
145 schema:name Psychopharmacology
146 schema:publisher Springer Nature
147 rdf:type schema:Periodical
148 sg:person.01134315436.13 schema:affiliation grid-institutes:grid.261356.5
149 schema:familyName Otsuki
150 schema:givenName Saburo
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134315436.13
152 rdf:type schema:Person
153 sg:person.01165304675.60 schema:affiliation grid-institutes:grid.261356.5
154 schema:familyName Hamamura
155 schema:givenName Takashi
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165304675.60
157 rdf:type schema:Person
158 sg:person.01222444440.80 schema:affiliation grid-institutes:grid.261356.5
159 schema:familyName Ujike
160 schema:givenName Hiroshi
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222444440.80
162 rdf:type schema:Person
163 sg:person.0702337163.01 schema:affiliation grid-institutes:grid.261356.5
164 schema:familyName Onoue
165 schema:givenName Taichi
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702337163.01
167 rdf:type schema:Person
168 sg:person.0713327777.20 schema:affiliation grid-institutes:grid.261356.5
169 schema:familyName Akiyama
170 schema:givenName Kazufumi
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713327777.20
172 rdf:type schema:Person
173 sg:pub.10.1007/bf00432713 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051366226
174 https://doi.org/10.1007/bf00432713
175 rdf:type schema:CreativeWork
176 sg:pub.10.1007/bf00439108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018127107
177 https://doi.org/10.1007/bf00439108
178 rdf:type schema:CreativeWork
179 sg:pub.10.1007/bf00496365 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020363995
180 https://doi.org/10.1007/bf00496365
181 rdf:type schema:CreativeWork
182 grid-institutes:grid.261356.5 schema:alternateName Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan
183 schema:name Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan
184 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...